Pilot Study on Deep Brain Stimulation for Opioid Use Disorder Initiated
A pilot study is underway to assess the safety and efficacy of deep brain stimulation targeting the nucleus accumbens in patients with treatment-refractory opioid use disorder.
Company
Pharmaceutical intelligence for Abbott with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.